Stoeltzing O - Search Results

1

Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo.

Moser C, Lang SA, Kainz S, Gaumann A, Fichtner-Feigl S, Koehl GE, Schlitt HJ, Geissler EK, Stoeltzing O. Moser C, et al. Among authors: stoeltzing o. Mol Cancer Ther. 2007 Nov;6(11):2868-78. doi: 10.1158/1535-7163.MCT-07-0410. Mol Cancer Ther. 2007. PMID: 18025273

2

Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.

Lang SA, Gaumann A, Koehl GE, Seidel U, Bataille F, Klein D, Ellis LM, Bolder U, Hofstaedter F, Schlitt HJ, Geissler EK, Stoeltzing O. Lang SA, et al. Among authors: stoeltzing o. Int J Cancer. 2007 Apr 15;120(8):1803-10. doi: 10.1002/ijc.22442. Int J Cancer. 2007. PMID: 17230506

3

Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.

Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke MH, Dietmaier W, Bolder U, Schlitt HJ, Geissler EK, Stoeltzing O. Lang SA, et al. Among authors: stoeltzing o. Mol Cancer Ther. 2007 Mar;6(3):1123-32. doi: 10.1158/1535-7163.MCT-06-0628. Mol Cancer Ther. 2007. PMID: 17363505

4

The direct effects of anti-vascular endothelial growth factor therapy on tumor cells.

Moser C, Lang SA, Stoeltzing O. Moser C, et al. Among authors: stoeltzing o. Clin Colorectal Cancer. 2007 Jul;6(8):564-71. doi: 10.3816/CCC.2007.n.023. Clin Colorectal Cancer. 2007. PMID: 17681102 Review.

5

Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth.

Lang SA, Moser C, Gaumann A, Klein D, Glockzin G, Popp FC, Dahlke MH, Piso P, Schlitt HJ, Geissler EK, Stoeltzing O. Lang SA, et al. Among authors: stoeltzing o. Clin Cancer Res. 2007 Nov 1;13(21):6459-68. doi: 10.1158/1078-0432.CCR-07-1104. Clin Cancer Res. 2007. PMID: 17975158

6

Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis.

Moser C, Schachtschneider P, Lang SA, Gaumann A, Mori A, Zimmermann J, Schlitt HJ, Geissler EK, Stoeltzing O. Moser C, et al. Among authors: stoeltzing o. Eur J Cancer. 2008 Jul;44(11):1577-86. doi: 10.1016/j.ejca.2008.04.003. Epub 2008 Apr 27. Eur J Cancer. 2008. PMID: 18445520

7

ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.

Moser C, Lang SA, Mori A, Hellerbrand C, Schlitt HJ, Geissler EK, Fogler WE, Stoeltzing O. Moser C, et al. Among authors: stoeltzing o. BMC Cancer. 2008 Jul 23;8:206. doi: 10.1186/1471-2407-8-206. BMC Cancer. 2008. PMID: 18651980 Free PMC article.

8

Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes.

Lang SA, Schachtschneider P, Moser C, Mori A, Hackl C, Gaumann A, Batt D, Schlitt HJ, Geissler EK, Stoeltzing O. Lang SA, et al. Among authors: stoeltzing o. Mol Cancer Ther. 2008 Nov;7(11):3509-18. doi: 10.1158/1535-7163.MCT-08-0373. Mol Cancer Ther. 2008. PMID: 19001434

9

Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice.

Lang SA, Moser C, Fichnter-Feigl S, Schachtschneider P, Hellerbrand C, Schmitz V, Schlitt HJ, Geissler EK, Stoeltzing O. Lang SA, et al. Among authors: stoeltzing o. Hepatology. 2009 Feb;49(2):523-32. doi: 10.1002/hep.22685. Hepatology. 2009. PMID: 19085954

10

Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.

Moser C, Lang SA, Stoeltzing O. Moser C, et al. Among authors: stoeltzing o. Anticancer Res. 2009 Jun;29(6):2031-42. Anticancer Res. 2009. PMID: 19528462 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters